Frederick G. Hayden, M.D.
Professor of Medicine and Pathology // University of Virginia School of Medicine
Professor Emeritus, Medicine: Infectious Diseases and International Health
International Advisor for Prevention and Treatment of Respiratory and Emerging Infectious Disease
Internationally recognized for his work with antiviral agents for the prevention and treatment of respiratory viral infections, Dr. Hayden works with the WHO-Global Influenza Programme and as an advisor to the International Several Acute Respiratory and Emerging Infection Consortium (ISARIC). He also serves as the Influenza Research Coordinator at Wellcome Trust and as a consultant to the NIAID supported Southeast Asia Infectious Diseases Clinical Research Network.
Dr. Hayden has been following the most recent progress of the DiversitAb™ antibodies for MERS-CoV and Ebola.
Frederick G. Hayden, M.D., is Richardson Professor of Clinical Virology in the Department of Medicine at the University of Virginia School of Medicine. Dr. Hayden received his medical degree from Stanford University School of Medicine in 1973.
After completing internal medicine residency and fellowship training in infectious diseases at the University of Rochester, he joined the faculty of the University of Virginia School of Medicine in 1978, initially in the Division of Epidemiology and Virology and subsequently in the Division of Infectious Diseases and International Health.
His principal research interests have been influenza and rhinovirus infections with a particular focus on the development and application of antiviral agents for these and other respiratory viral diseases. He has published over 300 peer-reviewed articles, chapters and reviews and co-edited the textbook Clinical Virology.
From April 2006 to August 2008 he was a Medical Officer in the Global Influenza Program at the World Health Organization and served as liaison to the Southeast Asia Influenza Clinical Research Network. Since September 2008 he has been working part-time on secondment from the University as influenza research coordinator at the Wellcome Trust in London.